142 related articles for article (PubMed ID: 7502893)
1. Immunity to Pseudomonas aeruginosa induced by OprF following intestinal immunization.
Cripps AW; Dunkley ML; Taylor DC; Cousins S; Clancy RL
Adv Exp Med Biol; 1995; 371B():761-3. PubMed ID: 7502893
[No Abstract] [Full Text] [Related]
2. Immunity to respiratory Pseudomonas aeruginosa infection: P. aeruginosa-specific T cells arising after intestinal immunization.
Dunkley ML; Cripps AW; Clancy RL
Adv Exp Med Biol; 1995; 371B():755-9. PubMed ID: 7502892
[No Abstract] [Full Text] [Related]
3. The protective role of pulmonary neutrophils in rats intestinally immunized with Pseudomonas aeruginosa.
Buret A; Dunkley M; Clancy RL; Cripps AW
Adv Exp Med Biol; 1995; 371B():765-9. PubMed ID: 7502894
[No Abstract] [Full Text] [Related]
4. Immunity to respiratory Pseudomonas aeruginosa infection: the role of gut-derived T helper cells and immune serum.
Dunkley ML; Cripps AW; Reinbott PW; Clancy RL
Adv Exp Med Biol; 1995; 371B():771-5. PubMed ID: 7502895
[No Abstract] [Full Text] [Related]
5. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
Krause A; Whu WZ; Xu Y; Joh J; Crystal RG; Worgall S
Vaccine; 2011 Mar; 29(11):2131-9. PubMed ID: 21215829
[TBL] [Abstract][Full Text] [Related]
6. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
[TBL] [Abstract][Full Text] [Related]
7. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R; Sharma A; Wu W; Sung B; Worgall S
Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
[TBL] [Abstract][Full Text] [Related]
8. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs.
Freihorst J; Merrick JM; Ogra PL
Infect Immun; 1989 Jan; 57(1):235-8. PubMed ID: 2491837
[TBL] [Abstract][Full Text] [Related]
10. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
[TBL] [Abstract][Full Text] [Related]
11. An animal model to study the mechanisms of immunity induced in the respiratory tract by intestinal immunization.
Cripps AW; Dunkley ML; Clancy RL; Wallace F; Buret A; Taylor DC
Adv Exp Med Biol; 1995; 371B():749-53. PubMed ID: 7502891
[No Abstract] [Full Text] [Related]
12. Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule.
Göcke K; Baumann U; Hagemann H; Gabelsberger J; Hahn H; Freihorst J; von Specht BU
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):167-71. PubMed ID: 12832121
[TBL] [Abstract][Full Text] [Related]
13. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.
Cripps AW; Dunkley ML; Clancy RL
Infect Immun; 1994 Apr; 62(4):1427-36. PubMed ID: 8132349
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.
Price BM; Barten Legutki J; Galloway DR; von Specht BU; Gilleland LB; Gilleland HE; Staczek J
FEMS Immunol Med Microbiol; 2002 Jun; 33(2):89-99. PubMed ID: 12052563
[TBL] [Abstract][Full Text] [Related]
15. Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.
Arnold H; Bumann D; Felies M; Gewecke B; Sörensen M; Gessner JE; Freihorst J; von Specht BU; Baumann U
Infect Immun; 2004 Nov; 72(11):6546-53. PubMed ID: 15501786
[TBL] [Abstract][Full Text] [Related]
16. Bombesin recovers gut-associated lymphoid tissue and preserves immunity to bacterial pneumonia in mice receiving total parenteral nutrition.
DeWitt RC; Wu Y; Renegar KB; King BK; Li J; Kudsk KA
Ann Surg; 2000 Jan; 231(1):1-8. PubMed ID: 10636095
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of properties of Pseudomonas aeruginosa recombinant outer membrane protein F (OprF)].
Zlygostev SA; Gataullin AG; Kaloshin AA; Mikhaĭlova NA; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2006; (7):43-7. PubMed ID: 17297879
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccines against chronic lung infections by Pseudomonas aeruginosa.
Staczek J; Gilleland LB; van der Heyde HC; Gilleland HE
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):147-53. PubMed ID: 12832118
[TBL] [Abstract][Full Text] [Related]
19. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
[TBL] [Abstract][Full Text] [Related]
20. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
